{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T08:14:11Z","timestamp":1789719251706,"version":"4.0.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2007,9,27]],"date-time":"2007-09-27T00:00:00Z","timestamp":1190851200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2008,4]]},"DOI":"10.1007\/s00277-007-0386-3","type":"journal-article","created":{"date-parts":[[2007,9,26]],"date-time":"2007-09-26T07:07:44Z","timestamp":1190790464000},"page":"269-276","source":"Crossref","is-referenced-by-count":52,"title":["Increased platelet, leukocyte, and coagulation activation in primary myelofibrosis"],"prefix":"10.1007","volume":"87","author":[{"given":"Alberto","family":"Alvarez-Larr\u00e1n","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo","family":"Arellano-Rodrigo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Carlos","family":"Reverter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abel","family":"Domingo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neus","family":"Villamor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dolors","family":"Colomer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"Cervantes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2007,9,27]]},"reference":[{"key":"386_CR1","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1046\/j.1365-2141.2003.04770.x","volume":"124","author":"A Alvarez-Larr\u00e1n","year":"2004","unstructured":"Alvarez-Larr\u00e1n A, Garcia-Pagan JC, Abraldes JG, Arellano E, Reverter JC, Bosch J, Cervantes F (2004) Increased CD11b neutrophil expression in Budd-Chiari syndrome or portal vein thrombosis secondary to polycythemia vera. Br J Haematol 124:329\u2013335","journal-title":"Br J Haematol"},{"key":"386_CR2","doi-asserted-by":"crossref","first-page":"13835","DOI":"10.1073\/pnas.250475997","volume":"97","author":"P Andr\u00e9","year":"2000","unstructured":"Andr\u00e9 P, Hartwell D, Hrachovinov\u00e1 I, Saffaripour S, Wagner DD (2000) Pro-coagulant state resulting from high levels of soluble P-selectin in blood. Proc Natl Acad Sci U S A 97:13835\u201313840","journal-title":"Proc Natl Acad Sci U S A"},{"key":"386_CR3","first-page":"169","volume":"91","author":"E Arellano-Rodrigo","year":"2006","unstructured":"Arellano-Rodrigo E, Alvarez-Larr\u00e1n A, Reverter JC, Villamor N, Colomer D, Cervantes F (2006) Increased platelet and leukocyte activation as contributing mechanisms for thrombosis in essential thrombocythemia and correlation with the JAK2 mutational status. Haematologica 91:169\u2013175","journal-title":"Haematologica"},{"key":"386_CR4","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1046\/j.1365-2141.1999.01262.x","volume":"104","author":"G Barosi","year":"1999","unstructured":"Barosi G, Ambrosetti A, Finelli G, Grossi A, Leoni P, Liberato NL, Petti MC, Pogliani E, Ricetti M, Rupoli S, Visani G, Tura S (1999) The Italian Consensus Conference on Diagnostic Criteria for Myelofibrosis with Myeloid Metaplasia. Br J Haematol 104:730\u2013737","journal-title":"Br J Haematol"},{"key":"386_CR5","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/S0140-6736(05)71142-9","volume":"365","author":"EJ Baxter","year":"2005","unstructured":"Baxter EJ, Scott LM, Campbell PJ, East C, Fourouclas N, Swanton S, Vassiliou GS, Bench AJ, Boyd EM, Curtin N, Scott MA, Erber WN, Green A (2005) Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders. Lancet 365:1054\u20131061","journal-title":"Lancet"},{"key":"386_CR6","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/sj.leu.2401270","volume":"13","author":"C Besses","year":"1999","unstructured":"Besses C, Cervantes F, Pereira A, Florensa L, Sole F, Hernandez-Boluda JC, Woessner S, Sans-Sabrafen J, Rozman C, Montserrat E (1999) Major vascular complications in essential thrombocythemia: a study of the predictive factors in a series of 148 patients. Leukemia 13:50\u2013154","journal-title":"Leukemia"},{"key":"386_CR7","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1046\/j.1365-2567.2002.01469.x","volume":"107","author":"MWJ Boehme","year":"2002","unstructured":"Boehme MWJ, Galle P, Stremmel W (2002) Kinetics of thrombomodulin release and endothelial cell injury by neutrophil-derived proteases and oxygen radicals. Immunology 107:340\u2013349","journal-title":"Immunology"},{"key":"386_CR8","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1046\/j.1365-2141.1997.782714.x","volume":"97","author":"F Cervantes","year":"1997","unstructured":"Cervantes F, Pereira A, Esteve J, Rafel M, Cobo F, Rozman C, Montserrat E (1997) Identification of \u2018short-lived\u2019 and \u2018long-lived\u2019 patients at presentation of idiopathic myelofibrosis. Br J Haematol 97:635\u2013640","journal-title":"Br J Haematol"},{"key":"386_CR9","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/sj.leu.2404048","volume":"20","author":"F Cervantes","year":"2006","unstructured":"Cervantes F, Alvarez-Larr\u00e1n A, Arellano-Rodrigo E, Granell M, Domingo A, Montserrat E (2006) Frequency and risk factors for thrombosis in idiopathic myelofibrosis: analysis in a series of 155 patients from a single institution. Leukemia 20:55\u201360","journal-title":"Leukemia"},{"key":"386_CR10","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1182\/blood.V80.5.1254.1254","volume":"80","author":"EM Conway","year":"1992","unstructured":"Conway EM, Nowakowski B, Steiner-Mosonyi M (1992) Human neutrophils synthesize thrombomodulin that does not promote thrombin-dependent protein C activation. Blood 80:1254\u20131263","journal-title":"Blood"},{"key":"386_CR11","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1111\/j.1365-2141.2004.05277.x","volume":"128","author":"MA Elliott","year":"2005","unstructured":"Elliott MA, Tefferi A (2005) Thrombosis and haemorrhage in polycythaemia vera and essential thrombocythaemia. Br J Haematol 128:275\u2013290","journal-title":"Br J Haematol"},{"key":"386_CR12","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1002\/jlb.58.5.575","volume":"58","author":"CS Engstad","year":"1995","unstructured":"Engstad CS, Lia K, Rekdal O, Olsen JO, Osterud B (1995) A novel biological effect of platelet factor 4 (PF4): enhancement of LPS-induced tissue factor activity in monocytes. J Leuk Biol 58:575\u2013581","journal-title":"J Leuk Biol"},{"key":"386_CR13","doi-asserted-by":"crossref","first-page":"4261","DOI":"10.1182\/blood.V96.13.4261","volume":"96","author":"A Falanga","year":"2000","unstructured":"Falanga A, Marchetti M, Evangelista V, Vignoli A, Licini M, Balicco M, Manarini S, Finazzi G, Cerletti C, Barbui T (2000) Polymorphonuclear leukocyte activation and hemostasis in patients with essential thrombocythemia and polycythemia vera. Blood 96:4261\u20134266","journal-title":"Blood"},{"key":"386_CR14","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.exphem.2005.01.015","volume":"33","author":"A Falanga","year":"2005","unstructured":"Falanga A, Marchetti M, Vignoli A, Balducci D, Barbui T (2005) Leukocyte-platelet interaction in patients with essential thrombocythemia and polycythemia vera. Exp Hematol 33:523\u2013530","journal-title":"Exp Hematol"},{"key":"386_CR15","first-page":"181","volume":"77","author":"R Fijnheer","year":"1997","unstructured":"Fijnheer R, Frijns CJM, Korteweg J, Rommes H, Peters JH, Sixma JJ, Nieuwenhuis HK (1997) The origin of P-selectin as a circulating plasma protein. Thromb Haemost 77:181\u2013185","journal-title":"Thromb Haemost"},{"key":"386_CR16","doi-asserted-by":"crossref","first-page":"656","DOI":"10.7326\/0003-4819-123-9-199511010-00003","volume":"123","author":"Gruppo Italiano Studio Policitemia","year":"1995","unstructured":"Gruppo Italiano Studio Policitemia (1995) Polycythemia vera: the natural history of 1213 patients followed for 20\u00a0years. Ann Intern Med 123:656\u2013664","journal-title":"Ann Intern Med"},{"key":"386_CR17","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1038\/nature03546","volume":"434","author":"C James","year":"2005","unstructured":"James C, Ugo V, Le Cou\u00e9dic JP, Staerk J, Delhommeau F, Lacout C, Garcon L, Raslova H, Berger R, Bennaceur-Griscelli A, Villeval JL, Constantinescu SN, Casadevall N, Vainchenker W (2005) A unique clonal JAK2 mutation leading to constitutive signaling causes polycythemia vera. Nature 434:1144\u20131148","journal-title":"Nature"},{"key":"386_CR18","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1046\/j.1365-2141.2000.02030.x","volume":"110","author":"MK Jensen","year":"2000","unstructured":"Jensen MK, de Nully Brown P, Lund BV, Nielsen OJ, Hasselbalch HC (2000) Increased platelet activation and abnormal glycoprotein content and redistribution in myeloproliferative disorders. Br J Haematol 110:116\u2013124","journal-title":"Br J Haematol"},{"key":"386_CR19","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1034\/j.1600-0609.2001.00359.x","volume":"66","author":"MK Jensen","year":"2001","unstructured":"Jensen MK, de Nully Brown P, Lund BV, Nielsen OJ, Hasselbalch HC (2001) Increased circulating platelet-leukocytes aggregates in myeloproliferative disorders is correlated to previous thrombosis, platelet activation and platelet count. Eur J Haematol 66:143\u2013151","journal-title":"Eur J Haematol"},{"key":"386_CR20","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1034\/j.1600-0609.2002.01732.x","volume":"69","author":"MK Jensen","year":"2002","unstructured":"Jensen MK, Riisbro R, de Nully Brown P, Brunner N, Hasselbach HC (2002) Elevated soluble urokinase plasminogen activator receptor in plasma from patients with idiopathic myelofibrosis or polycythemia vera. Eur J Haematol 69:43\u201349","journal-title":"Eur J Haematol"},{"key":"386_CR21","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1056\/NEJMoa051113","volume":"352","author":"R Kralovics","year":"2005","unstructured":"Kralovics R, Passamonti F, Buser AS, Teo SS, Tiedt R, Passweg JR, Tichelli A, Cazzola M, Skoda RC (2005) A gain-of-function mutation of JAK2 in myeloproliferative disorders. New Engl J Med 352:1779\u20131790","journal-title":"New Engl J Med"},{"key":"386_CR22","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0308-2261(21)00079-5","volume":"43","author":"K Lennert","year":"1975","unstructured":"Lennert K, Naghai K, Schwarze EW (1975) Patho-anatomical features of the bone marrow. Clin Haematol 43:331\u2013351","journal-title":"Clin Haematol"},{"key":"386_CR23","first-page":"29","volume":"79","author":"P Leoni","year":"1994","unstructured":"Leoni P, Rupoli S, Lai G, Brunelli MA, Belmonte MM, Pugnaloni A, Rabini RA, Mazzanti L, Biagini G (1994) Platelet abnormalities in idiopathic myelofibrosis: functional, biochemical and immunomorphological correlations. Haematologica 79:29\u201339","journal-title":"Haematologica"},{"key":"386_CR24","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.ccr.2005.03.023","volume":"7","author":"RL Levine","year":"2005","unstructured":"Levine RL, Wadleigh M, Cools J, Ebertm BL, Wernig G, Huntly BJ, Boggon TJ, Wlodarska I, Clark JJ, Moore S, Adelsperger J, Koo S, Lee JC, Gabriel S, Mercher T, D\u2019Andrea A, Frohling S, Dohner K, Marynen P, Vandenberghe P, Mesa RA, Tefferi A, Griffin JD, Eck MJ, Sellers WR, Meyerson M, Golub TR, Lee SJ, Gilliland DG (2005) Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia and myeloid metaplasia with myelofibrosis. Cancer Cell 7:387\u2013397","journal-title":"Cancer Cell"},{"key":"386_CR25","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1182\/blood.V96.4.1342","volume":"96","author":"A Schmitt","year":"2000","unstructured":"Schmitt A, Jouault H, Guichard J, Wendling F, Drouin A, Cramer EM (2000) Pathologic interaction between megakaryocytes and polymorphonuclear leukocytes in myelofibrosis. Blood 96:1342\u20131347","journal-title":"Blood"},{"key":"386_CR26","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1055\/s-0037-1615088","volume":"79","author":"G Schmitz","year":"1998","unstructured":"Schmitz G, Rothe G, Ruf A, Barlage S, Tschope D, Clemetson KJ, Goodall AH, Michelson AD, Nurden AT, Shankey TV (1998) European Working Group on clinical cell analysis: consensus protocol for the flow cytometric characterisation of platelet function. Thromb Haemost 79:885\u2013896","journal-title":"Thromb Haemost"},{"key":"386_CR27","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1182\/blood.V70.1.307.307","volume":"70","author":"SJ Shattil","year":"1987","unstructured":"Shattil SJ, Cunningham M, Hoxie JA (1987) Detection of activated platelets in whole blood using activation-dependent monoclonal antibodies and flow cytometry. Blood 70:307\u2013315","journal-title":"Blood"},{"key":"386_CR28","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1111\/j.1365-2141.2005.05776.x","volume":"131","author":"A Tefferi","year":"2005","unstructured":"Tefferi A, Lasho TL, Steensma DP, Mesa RA, Li CY, Wadleigh M, Gilliland DG (2005) The JAK2V617F tyrosine kinase mutation in myelofibrosis with myeloid metaplasia: lineage specificity and clinical correlates. Br J Haematol 131:320\u2013328","journal-title":"Br J Haematol"},{"key":"386_CR29","doi-asserted-by":"crossref","first-page":"2612","DOI":"10.1182\/blood.V99.7.2612","volume":"99","author":"JF Viallard","year":"2002","unstructured":"Viallard JF, Solanilla A, Gauthier B, Contin C, D\u00e9chanet J, Grosset C, Moreau JF, Praloran V, Nurden P, Pellegrin JL, Nurden AT, Ripoche J (2002) Increased soluble and platelet-associated CD40 ligand in essential thrombocythemia and reactive thrombocytosis. Blood 99:2612\u20132614","journal-title":"Blood"},{"key":"386_CR30","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0049-3848(02)00354-7","volume":"108","author":"T Villmow","year":"2003","unstructured":"Villmow T, Kemkes-Matthes B, Matzdorff AC (2003) Markers of platelet activation and platelet-leukocyte interaction in patients with myeloproliferative syndromes. Thromb Res 108:139\u2013145","journal-title":"Thromb Res"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-007-0386-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00277-007-0386-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-007-0386-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,24]],"date-time":"2021-08-24T08:25:21Z","timestamp":1629793521000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00277-007-0386-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,9,27]]},"references-count":30,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2008,4]]}},"alternative-id":["386"],"URL":"https:\/\/doi.org\/10.1007\/s00277-007-0386-3","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,9,27]]}}}